Literature DB >> 20554810

Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method.

E R Gaunt1, A Hardie, E C J Claas, P Simmonds, K E Templeton.   

Abstract

Four human coronaviruses (HCoV-229E, HCoV-HKU1, HCoV-NL63, and HCoV-OC43) are associated with a range of respiratory outcomes, including bronchiolitis and pneumonia. Their epidemiologies and clinical characteristics are poorly described and are often reliant on case reports. To address these problems, we conducted a large-scale comprehensive screening for all four coronaviruses by analysis of 11,661 diagnostic respiratory samples collected in Edinburgh, United Kingdom, over 3 years between July 2006 and June 2009 using a novel four-way multiplex real-time reverse transcription-PCR (RT-PCR) assay. Coronaviruses were detected in 0.3 to 0.85% of samples in all age groups. Generally, coronaviruses displayed marked winter seasonality between the months of December and April and were not detected in summer months, which is comparable to the pattern seen with influenza viruses. HCoV-229E was the exception; detection was confined to the winter of 2008 and was sporadic in the following year. There were additional longer-term differences in detection frequencies between seasons, with HCoV-OC43 predominant in the first and third seasons and HCoV-HKU1 dominating in the second (see Results for definitions of seasons). A total of 11 to 41% of coronaviruses detected were in samples testing positive for other respiratory viruses, although clinical presentations of coronavirus monoinfections were comparable to those of viruses which have an established role in respiratory disease, such as respiratory syncytial virus, influenza virus, and parainfluenza viruses. The novel multiplex assay for real-time pan-coronavirus detection enhances respiratory virus diagnosis, overcomes potential diagnostic problems arising through seasonal variation in coronavirus frequency, and provides novel insights into the epidemiology and clinical implications of coronaviruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554810      PMCID: PMC2916580          DOI: 10.1128/JCM.00636-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Coronavirus HKU1 and other coronavirus infections in Hong Kong.

Authors:  Susanna K P Lau; Patrick C Y Woo; Cyril C Y Yip; Herman Tse; Hoi-wah Tsoi; Vincent C C Cheng; Paul Lee; Bone S F Tang; Chris H Y Cheung; Rodney A Lee; Lok-yee So; Yu-lung Lau; Kwok-hung Chan; Kwok-yung Yuen
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  The Tecumseh study of respiratory illness. VI. Frequency of and relationship between outbreaks of coronavirus infection.

Authors:  A S Monto; S K Lim
Journal:  J Infect Dis       Date:  1974-03       Impact factor: 5.226

3.  Epidemiology and clinical presentations of human coronavirus NL63 infections in hong kong children.

Authors:  Ting Fan Leung; Chung Yi Li; Wai Yip Lam; Gary W K Wong; Edmund Cheuk; Margaret Ip; Pak Cheung Ng; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

4.  Coronavirus HKU1 infection in the United States.

Authors:  Frank Esper; Carla Weibel; David Ferguson; Marie L Landry; Jeffrey S Kahn
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

5.  Virologic studies of acute respiratory disease in young adults. V. Coronavirus 229E infections during six years of surveillance.

Authors:  D Hamre; M Beem
Journal:  Am J Epidemiol       Date:  1972-08       Impact factor: 4.897

6.  Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients.

Authors:  Giuseppe Gerna; Elena Percivalle; Antonella Sarasini; Giulia Campanini; Antonio Piralla; Francesca Rovida; Emilia Genini; Antonietta Marchi; Fausto Baldanti
Journal:  J Clin Virol       Date:  2007-01-10       Impact factor: 3.168

7.  An outbreak of coronavirus OC43 respiratory infection in Normandy, France.

Authors:  Astrid Vabret; Thomas Mourez; Stéphanie Gouarin; Joëlle Petitjean; François Freymuth
Journal:  Clin Infect Dis       Date:  2003-04-04       Impact factor: 9.079

8.  Seroepidemiologic survey of coronavirus (strain OC 43) related infections in a children's population.

Authors:  H S Kaye; H B Marsh; W R Dowdle
Journal:  Am J Epidemiol       Date:  1971-07       Impact factor: 4.897

9.  Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China.

Authors:  Susan S Chiu; Kwok Hung Chan; Ka Wing Chu; See Wai Kwan; Yi Guan; Leo Lit Man Poon; J S M Peiris
Journal:  Clin Infect Dis       Date:  2005-05-10       Impact factor: 9.079

10.  Croup is associated with the novel coronavirus NL63.

Authors:  Lia van der Hoek; Klaus Sure; Gabriele Ihorst; Alexander Stang; Krzysztof Pyrc; Maarten F Jebbink; Gudula Petersen; Johannes Forster; Ben Berkhout; Klaus Uberla
Journal:  PLoS Med       Date:  2005-08-23       Impact factor: 11.069

View more
  276 in total

1.  Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19.

Authors:  Mohammad M Sajadi; Parham Habibzadeh; Augustin Vintzileos; Shervin Shokouhi; Fernando Miralles-Wilhelm; Anthony Amoroso
Journal:  SSRN       Date:  2020-03-09

Review 2.  Certainty of success: three critical parameters in coronavirus vaccine development.

Authors:  David C Kaslow
Journal:  NPJ Vaccines       Date:  2020-05-25       Impact factor: 7.344

3.  Diversity and Evolutionary Histories of Human Coronaviruses NL63 and 229E Associated with Acute Upper Respiratory Tract Symptoms in Kuala Lumpur, Malaysia.

Authors:  Maryam Nabiel Al-Khannaq; Kim Tien Ng; Xiang Yong Oong; Yong Kek Pang; Yutaka Takebe; Jack Bee Chook; Nik Sherina Hanafi; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  Am J Trop Med Hyg       Date:  2016-02-29       Impact factor: 2.345

Review 4.  Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.

Authors:  Nicole Baumgarth; Janko Nikolich-Žugich; F Eun-Hyung Lee; Deepta Bhattacharya
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

5.  A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry.

Authors:  Mohamed El-Tholoth; Haim H Bau; Jinzhao Song
Journal:  ChemRxiv       Date:  2020-02-19

6.  Evidence for an Ancestral Association of Human Coronavirus 229E with Bats.

Authors:  Victor Max Corman; Heather J Baldwin; Adriana Fumie Tateno; Rodrigo Melim Zerbinati; Augustina Annan; Michael Owusu; Evans Ewald Nkrumah; Gael Darren Maganga; Samuel Oppong; Yaw Adu-Sarkodie; Peter Vallo; Luiz Vicente Ribeiro Ferreira da Silva Filho; Eric M Leroy; Volker Thiel; Lia van der Hoek; Leo L M Poon; Marco Tschapka; Christian Drosten; Jan Felix Drexler
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

7.  Human coronavirus and severe acute respiratory infection in Southern Brazil.

Authors:  Hygor Trombetta; Heloisa Z Faggion; Jaqueline Leotte; Meri B Nogueira; Luine R R Vidal; Sonia M Raboni
Journal:  Pathog Glob Health       Date:  2016-05-19       Impact factor: 2.894

8.  TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.

Authors:  Stephanie Bertram; Ronald Dijkman; Matthias Habjan; Adeline Heurich; Stefanie Gierer; Ilona Glowacka; Kathrin Welsch; Michael Winkler; Heike Schneider; Heike Hofmann-Winkler; Volker Thiel; Stefan Pöhlmann
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

Review 9.  Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.

Authors:  Yuhang Wang; Matthew Grunewald; Stanley Perlman
Journal:  Methods Mol Biol       Date:  2020

10.  Human Coronavirus-Associated Influenza-Like Illness in the Community Setting in Peru.

Authors:  Hugo Razuri; Monika Malecki; Yeny Tinoco; Ernesto Ortiz; M Claudia Guezala; Candice Romero; Abel Estela; Patricia Breña; Maria-Luisa Morales; Erik J Reaves; Jorge Gomez; Timothy M Uyeki; Marc-Alain Widdowson; Eduardo Azziz-Baumgartner; Daniel G Bausch; Verena Schildgen; Oliver Schildgen; Joel M Montgomery
Journal:  Am J Trop Med Hyg       Date:  2015-08-31       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.